Xiaolin Dong

597 citations
15 papers · 216 indexed · h-index 8
Topics
Diabetes Treatment and Management (11 papers)Diabetes Management and Research (7 papers)Metabolism, Diabetes, and Cancer (6 papers)
Partner nations
ChinaGermanyFrance

In The Last Decade

Xiaolin Dong

13 papers receiving 212 citations

Peers

Xiaolin Dong
Comparison fields: 5 of 37
  • Endocrinology, Diabetes and Metabolism 181
  • Molecular Biology 93
  • Public Health, Environmental and Occupational Health 40
  • Pharmacology 38
  • Surgery 36
Replace Esteban Jódar-Gimeno with:
Esteban Jódar-Gimeno Spain
Neil Chappell United States
Huibiao Quan China
Vesna Šalamun Slovenia
Mathilde Svendstrup Denmark
J. Marathe Australia
Mark O. Goodarzi United States
Aylmer Tang United States
Zsolt Gaál Hungary
Xiaolin Dong relative to Esteban Jódar-Gimeno Spain Esteban Jódar-Gimeno's profile →
Citations per field
00.5×
Esteban Jódar-Gimeno · 1×
Citations per year

Countries citing papers authored by Xiaolin Dong

Since Specialization
Citations

This map shows the geographic impact of Xiaolin Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaolin Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaolin Dong more than expected).

Fields of papers citing papers by Xiaolin Dong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaolin Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaolin Dong. The network helps show where Xiaolin Dong may publish in the future.

Co-authorship network of co-authors of Xiaolin Dong

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaolin Dong. A scholar is included among the top collaborators of Xiaolin Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaolin Dong. Xiaolin Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1 0
2 0
3 3
4 1
5 4
6 1
7 7
8 18
9 17
10 15
11 2
12 71
13 20
14 7
15 50

About Xiaolin Dong

Xiaolin Dong is a scholar working on Endocrinology, Diabetes and Metabolism, Aquatic Science and Molecular Biology, having authored 15 papers that have together received 216 indexed citations. Recurring topics across this work include Diabetes Treatment and Management (11 papers), Diabetes Management and Research (7 papers) and Metabolism, Diabetes, and Cancer (6 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (181 citations), Pharmacology (38 citations) and Public Health, Environmental and Occupational Health (40 citations). Xiaolin Dong has collaborated with scholars based in China, Germany and France. Frequent co-authors include Guoyue Yuan, Li Chen, Yang Liu, Ming Liu, Yu Sun, Linong Ji, Freddy G. Eliaschewitz, Soo Lim, Yufeng Li and Yiming Li. Their work appears in journals such as Diabetes, Clinical Pharmacokinetics and Oncotarget.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026